Prospective Grant of an Exclusive Patent License: Development of a CD276 Antibody-Drug Conjugate for the Treatment of Solid Tumors

TitleProspective Grant of an Exclusive Patent License: Development of a CD276 Antibody-Drug Conjugate for the Treatment of Solid Tumors
ToC Doc Development of a CD276 Antibody-Drug Conjugate for the Treatment of Solid Tumors
Docket Number2023-04411
Type Notice
Subject Prospective Grant of an Exclusive Patent License:
Development of a CD276 Antibody-Drug Conjugate for the Treatment of Solid Tumors
Publication Date2023-03-03
Last Updated Date 2023-03-02 08:15:12 -0500
Last Public Inspection2023-03-02
Filed At2023-03-02T08:45:00.000-05:00
PDF 2023-04411_PI.pdf (91599 bytes)
Download TXT / HTML / JSON
Number of Pages 4
Filing Typeregular
AgenciesNational Institutes of Health

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021